Pauci-immune glomerulonephritis in individuals with disease associated with levamisole-adulterated cocaine: a series of 4 cases.
Exposure to levamisole-adulterated cocaine can induce a distinct clinical syndrome characterized by retiform purpura and/or agranulocytosis accompanied by an unusual constellation of serologic abnormalities including antiphospholipid antibodies, lupus anticoagulants, and very high titers of antineutrophil cytoplasmic antibodies. Two recent case reports suggest that levamisole-adulterated cocaine may also lead to renal disease in the form of pauci-immune glomerulonephritis. To explore this possibility, we reviewed cases of pauci-immune glomerulonephritis between 2010 and 2012 at an inner city safety net hospital where the prevalence of levamisole in the cocaine supply is known to be high. We identified 3 female patients and 1 male patient who had biopsy-proven pauci-immune glomerulonephritis, used cocaine, and had serologic abnormalities characteristic of levamisole-induced autoimmunity. Each also had some other form of clinical disease known to be associated with levamisole, either neutropenia or cutaneous manifestations. One patient had diffuse alveolar hemorrhage. Three of the 4 patients were treated with short courses of prednisone and cyclophosphamide, 2 of whom experienced stable long-term improvement in their renal function despite ongoing cocaine use. The remaining 2 patients developed end-stage renal disease and became dialysis-dependent. This report supports emerging concern of more wide spread organ toxicity associated with the use of levamisole-adulterated cocaine.
Divisions of Rheumatology (AQC, JG, JBI) and Nephrology (DST, BB, RS), Department of Medicine, San Francisco General Hospital and University of California, San Francisco; and Department of Pathology (KYJ), University of California, San Francisco, California.
Adam Q
AQ
Carlson
Delphine S
DS
Tuot
Kuang-Yu
KY
Jen
Brad
B
Butcher
Jonathan
J
Graf
Ramin
R
Sam
John B
JB
Imboden
D000328:Adult; D003042:Cocaine / Q000506:poisoning*; D019970:Cocaine-Related Disorders / Q000150:complications*; D004340:Drug Contamination; D005260:Female; D005921:Glomerulonephritis / Q000139:chemically induced* / Q000276:immunology; D006801:Humans; D007978:Levamisole / Q000506:poisoning*; D008297:Male; D008875:Middle Aged
D007978:Levamisole; D003042:Cocaine